SCHEMBL3677823

SCHEMBL3677823

O=C(c1ccccn1)N(CCO)CCO

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.50
LMNA P02545 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
P4HTM Q9NXG6 1/20 0.50
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
GSK3B P49841 1/20 0.44
ALOX15 P16050 1/20 0.44
GAA P10253 2/20 0.43
KDM4E B2RXH2 4/20 0.43
OPRK1 P41145 1/20 0.43
EPHX2 P34913 1/20 0.42
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19404527 0.84 TP53 (0.58) CES2CES1L3MBTL1LMNANAPRT
SCHEMBL26676066 0.83 ALDH1A1 (0.50) CES2CES1L3MBTL1LMNANAPRT
SCHEMBL30975214 0.80 ALDH1A1 (0.58) CES2CES1L3MBTL1LMNANAPRT
SCHEMBL6185976 0.80 CES2 (0.53) CES2CES1L3MBTL1LMNANAPRT
SCHEMBL8405203 0.80 ALDH1A1 (0.58) CES2CES1L3MBTL1LMNANAPRT
SCHEMBL7656985 0.79 L3MBTL1 (0.53) L3MBTL1LMNAKMT2AALOX15GAA
SCHEMBL10458612 0.79 KDM4E (0.55) L3MBTL1LMNAALDH1A1SMN1; SMN2ALOX15
SCHEMBL8611143 0.79 KDM4E (0.55) L3MBTL1LMNAALDH1A1SMN1; SMN2ALOX15
SCHEMBL30975242 0.78 KDM4E (0.52) CES2CES1L3MBTL1LMNANAPRT
SCHEMBL6870340 0.77 OPRK1 (0.57) CES2CES1L3MBTL1LMNANAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2166846-A1 INHIBITORS OF JANUS KINASES Merck Sharp & Dohme Corp. (US) 2010-03-31 EP claimed
WO-2008156726-A1 INHIBITORS OF JANUS KINASES MERCK & CO., INC. (US) 2008-12-24 WO claimed
WO-2024131265-A1 COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF 中国科学院合肥物质科学研究院 2024-06-27 WO disclosed
CN-115505098-A Zwitterionic polyurethane and preparation method and application thereof 中山大学 2022-12-23 CN disclosed
EP-2991981-B1 DIAMINOPYRAZINE COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF BOEHRINGER INGELHEIM INT (DE) 2017-03-01 EP disclosed
WO-2014177469-A1 DIAMINOPYRAZINE COMPOUNDS, MEDICAMENTS CONTAINING SAID COMPOUNDS, USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH,M (DE) 2014-11-06 WO disclosed
EP-2166846-A1 INHIBITORS OF JANUS KINASES Merck Sharp & Dohme Corp. (US) 2010-03-31 EP disclosed
WO-2008156726-A1 INHIBITORS OF JANUS KINASES MERCK & CO., INC. (US) 2008-12-24 WO disclosed